Effectiveness and safety of tapentadol prolonged release with tapentadol immediate release on-demand for the management of severe, chronic osteoarthritis-related knee pain: results of an open-label, phase 3b study

This open-label, phase 3b study (ClinicalTrials.gov Identifier: NCT00983073) evaluated the effectiveness, and tolerability of tapentadol for severe, chronic osteoarthritis knee pain that was inadequately managed with World Health Organization (WHO) Step I or II analgesics or co-analgesics, or that w...

Descripción completa

Detalles Bibliográficos
Autores principales: Steigerwald, Ilona, Müller, Matthias, Kujawa, Jolanta, Balblanc, Jean-Charles, Calvo-Alén, Jaime
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3392842/
https://www.ncbi.nlm.nih.gov/pubmed/22792000
http://dx.doi.org/10.2147/JPR.S30540

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3392842/
https://www.ncbi.nlm.nih.gov/pubmed/22792000
http://dx.doi.org/10.2147/JPR.S30540

Ejemplares similares